Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Local Sustained Release of Prostaglandin E1 Induces Neovascularization in Murine Hindlimb Ischemia
Jiro EsakiHisashi SakaguchiAkira MaruiShyamal Chandra BirYoshio AraiYuhong HuangHideki TsubotaToshiya KanajiTadashi IkedaRyuzo Sakata
Author information
JOURNAL FREE ACCESS Advance online publication

Article ID: CJ-08-0999


Background: Although intravenous administration of prostaglandin E1 (PGE1) is commonly used in the treatment of peripheral arterial disease, it rapidly becomes inactivated in the lung. Whether local administration of sustained-release (SR) PGE1 enhances neovascularization in murine hindlimb ischemia was investigated. Methods and Results: Poly lactide-co-glycolide (PLGA) microspheres were the 4-week SR carrier of PGE1. C57BL/6 mice with unilateral hindlimb ischemia were randomly treated as follows: no treatment (Group N); single administration of 100 μg/kg PGE1 solution (Group L) into the ischemic muscles; daily systemic administration of PGE1 for 2 weeks at a total dose 100 μg/kg (Group S); and single administration of PGE1-100 μg/kg-loaded PLGA (Group P100) into the ischemic muscles. The blood perfusion in Group P100 was higher than in Groups N, L and S (ischemic/nonischemic blood perfusion ratio 88 ±11% vs 73 ±11% (P<0.01), 77 ±9% (P<0.05), 79 ±11% (P<0.05), respectively). Vascular density and αSMA-positive-vessel density in Group P100 were higher than in Groups N, L and S (vascular density (vessels/m2): 241 ±39 vs 169 ±49 (P<0.01), 169 ±54 (P<0.01), 201 ±42 (P<0.05), respectively; αSMA-positive-vessel density (vessels/m2): 34 ±10 vs 18 ±6 (P<0.01), 21 ±11 (P<0.01), 22 ±10 (P<0.01), respectively) Conclusions: Local administration of a single dose of SR PGE1 enhances neovascularization in mice hindlimb ischemia more efficiently than daily systemic administration.

Information related to the author